A Study of IBI377 in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease

NCT04220632 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Adverse events of the first patient

Conditions

GVHD,Acute

Interventions

DRUG: Itacitinib
DRUG: Prednisone
DRUG: Methylprednisolone

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.